- Report
- April 2023
- 80 Pages
Germany
From €668EUR$750USD£577GBP
€1335EUR$1,500USD£1,154GBP
- Report
- April 2023
- 80 Pages
France
From €668EUR$750USD£577GBP
€1335EUR$1,500USD£1,154GBP
- Report
- April 2023
- 80 Pages
China
From €668EUR$750USD£577GBP
€1335EUR$1,500USD£1,154GBP
- Report
- April 2023
- 300 Pages
Global
From €1113EUR$1,250USD£961GBP
€2225EUR$2,500USD£1,923GBP
- Report
- August 2022
- 116 Pages
Global
From €4006EUR$4,500USD£3,461GBP
- Report
- July 2024
- 153 Pages
Global
From €3216EUR$3,613USD£2,778GBP
€3783EUR$4,250USD£3,268GBP
- Report
- July 2024
- 90 Pages
Global
From €3500EUR$4,212USD£3,130GBP
- Report
- April 2022
- 87 Pages
Global
From €3500EUR$4,212USD£3,130GBP
- Report
- March 2024
- 132 Pages
Global
From €846EUR$950USD£731GBP
In Vitro Diagnostics Quality Control (IVD QC) is a specialized field of laboratory medicine that focuses on the quality assurance of diagnostic tests. It involves the use of quality control materials, such as reference materials, proficiency testing, and quality assurance programs, to ensure the accuracy and reliability of test results. Quality control is essential for the accurate diagnosis and treatment of patients, as well as for the development of new diagnostic tests. Quality control is also important for the regulatory compliance of diagnostic tests.
IVD QC is a rapidly growing field, with a wide range of products and services available to meet the needs of laboratories. Companies in the market include Bio-Rad Laboratories, Siemens Healthineers, Thermo Fisher Scientific, Roche Diagnostics, Abbott Laboratories, and Becton Dickinson. Show Less Read more